NUCLEOLIN and glioma: In order to address the expression of NCL in glial brain tumor progression (from WHO low- to high-grade tumors; refs. 62–64), we referred to tissue microarrays (TMAs) of human glioma stained by IHC for NCL and the nuclear marker Mayer’s hemalum (Figure 2, A–D).